India News | Malavika Kaur Makol, Bloomberg | Thursday July 1, 2021
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
www.ndtv.com